The main purpose of the Screening Group is to provide hit identification and hit-to-lead optimization contract services to the biotech and pharmaceutical industry. We are also open to discuss shared-risk exploratory hit finding projects with the industry or academic partners… (more…)
The growing Bienta currently employs 18 FTEs and is capable of performing HTS with a broad variety of biochemical and cell-based assays… (more…)
Our Molecular Modeling group provides cheminformatics, molecular modeling, virtual screening and computational biology services aiming to accelerate hit identification, lead generation and lead optimization stages of the drug discovery process… (more…)